Trial Profile
An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2020
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Cognition disorders; Post-traumatic stress disorders
- Focus Therapeutic Use
- 13 Oct 2014 New trial record